Publications by authors named "Bill Frame"

Claim this Profile
E
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain.
Matthew M Hutmacher, Bill Frame, Raymond Miller, Kenneth Truitt, Domenico Merante

J Clin Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.
Bojan Lalovic, Matt Hutmacher, Bill Frame, Raymond Miller

J Clin Pharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic-pharmacodynamic modeling of biological agents: when modeling meets reality.
Diane R Mould, Bill Frame

J Clin Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder.
Bill Frame, Raymond Miller, Matthew M Hutmacher

J Pharmacokinet Pharmacodyn· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
Kenneth F Koral, John P Huberty, Bill Frame, Katherine K Matthay, John M Maris

Eur J Nucl Med Mol Imaging· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative method for population pharmacokinetic data analysis under noncompliance.
Pankaj Gupta, Matthew M Hutmacher, Bill Frame, Raymond Miller

J Pharmacokinet Pharmacodyn· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed effects modeling of weight change associated with placebo and pregabalin administration.
Bill Frame, Stuart L Beal, Raymond Miller, Jeannette Barrett, Paula Burger

J Pharmacokinet Pharmacodyn· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-part mixture model for longitudinal adverse event severity data.
Kenneth G Kowalski, Lynn McFadyen, Matthew M Hutmacher, Bill Frame, Raymond Miller

J Pharmacokinet Pharmacodyn· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
Raymond Miller, Bill Frame, Brian Corrigan, Paula Burger, Howard Bockbrader

Clin Pharmacol Ther· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of mixture modeling with count data using NONMEM.
Bill Frame, Raymond Miller, Richard L Lalonde

J Pharmacokinet Pharmacodyn· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis